LYNDEN MCLEAN: Open Payments
NPI 1366168866 · LINCOLN, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$876 in 40 payments from 17 companies in 2025. Trend: 2023 $684 · 2024 $2,988 · 2025 $876
Food & beverage: $740Education: $136
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $169 |
| JAZZ PHARMACEUTICALS INC. | 5 | $122 |
| Regeneron Healthcare Solutions, Inc. | 2 | $97 |
| Amgen Inc. | 5 | $80 |
| GENZYME CORPORATION | 4 | $62 |
| Verona Pharma, Inc. | 3 | $54 |
| Grifols USA, LLC | 2 | $49 |
| Inspire Medical Systems, Inc. | 2 | $41 |
| United Therapeutics Corporation | 2 | $39 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $31 |
Products named: DUPIXENT, XYWAV, AIRSUPRA, TEZSPIRE, Ohtuvayre, Prolastin-C Liquid, FASENRA, INSPIRE.
Industry payments across NE — which companies pay providers there.
